loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: [125I]CCK-8

    Menu

    [125I]CCK-8

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 210850 / DOSAGE - POWDER;INTRAVENOUS - 0.005MG/VIAL

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SINCALIDE(UNII: M03GIQ7Z6P)
    (SINCALIDE - UNII:M03GIQ7Z6P)     		SINCALIDE5ug in 5

    Inactive Ingredients

    Ingredient Name
    Fresenius Kabi USA, LLC
    General Injectables & Vaccines, Inc
    Jubilant HollisterStier LLC
    MAIA Pharmaceuticals, Inc.
    Arginine hydrochloride(F7LTH1E20Y)
    LYSINE HYDROCHLORIDE(JNJ23Q2COM)
    Mannitol(3OWL53L36A)
    METHIONINE(AE28F7PNPL)
    Pentetic acid(7A314HQM0I)  
    POLYSORBATE 20(7T1F30V5YH) 
    potassium phosphate, dibasic(CI71S98N1Z) 
    SODIUM METABISULFITE(4VON5FNS3C)